Drug intelligence / Profile preview

eucalyptus oil (Ego Pharmaceuticals)

Development stage
Unknown
Lead developer
Ego Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

Eucalyptus oil is a natural plant extract and essential oil derived from the leaves of Eucalyptus species, primarily *Eucalyptus globulus*. In the field of pediculosis, it is developed and marketed by Ego Pharmaceuticals as the primary active component of the MOOV Head Lice product range for the treatment of head lice infestation (pediculosis capitis) in children. Unlike traditional neurotoxic pediculicides, eucalyptus oil operates via a physical and mechanical mode of action, disrupting the biomechanical mechanisms of the head louse and preventing the development of resistance. It is typically formulated topically, often in combination with other essential oils such as *Leptospermum petersonii* (lemon-scented tea tree) oil, and has been clinically validated in Phase 4 trials in Australia.

Other names
Eucalyptus globulus oilEucalyptus globulus leaf oil
02

Targets

TRPA1 (Transient receptor potential cation channel subfamily A member 1)HTR3A (5-hydroxytryptamine receptor 3A)

Beyond the preview

Go deeper on eucalyptus oil (Ego Pharmaceuticals).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on eucalyptus oil (Ego Pharmaceuticals).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call